Although the disorder is rare, with a prevalence of one to 10 cases per million in adults and one to 3.2 cases per million in children, early recognition and treatment are important ways to decrease the morbidity of systemic complications. Dermatomyositis is an idiopathic inflammatory myopathy with characteristic skin manifestations. Hydroxychloroquine & methotrexate Plaquenil and visual field testing Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Background Hydroxychloroquine sulfate and other antimalarial drugs have been used successfully as adjunctive therapy for patients with cutaneous lesions of dermatomyositis over the past 20 years. An increased incidence of cutaneous reactions to hydroxychloroquine has been postulated to occur in patients with dermatomyositis. Nov 01, 2001 Dermatomyositis is an idiopathic inflammatory myopathy with characteristic skin manifestations. Although the disorder is rare, with a prevalence of one to 10 cases per million in adults and one to. Poor prognostic indicators include poorly responsive disease, delay in diagnosis and the presence of malignancy. Patient management includes careful evaluation for underlying malignancy and liberal use of physical therapy, antihistamines, sunscreen and oral corticosteroids. Hydroxychloroquine for dermatomyositis Hydroxychloroquine User Reviews for Dermatomyositis at, Adverse Cutaneous Reactions to Hydroxychloroquine Are More. Plaquenil black box warningDr gave me plaquenil to samplePlaquenil interactions herbsPlaquenil chronic urticaria Dermatomyositis is a disease that causes rash and muscle weakness. Learn more about the symptoms, causes, and treatments of this condition. Antimalarial medicines like hydroxychloroquine treat. What Is Dermatomyositis? What Are the Symptoms?. Dermatomyositis - American Family Physician. Hydroxychloroquine Plaquenil and Hair Loss Is my.. Sep 13, 2018 Hydroxychloroquine sulfate is frequently used to treat patients with dermatomyositis. It has been associated with an increased risk of adverse skin reactions in these patients. This study was performed to find out whether subsets of adult dermatomyositis patients, characterized by antibodies, are at increased risk for these skin eruptions. What is the treatment of dermatomyositis? The primary aim of treatment is to control the skin disease and muscle disease. An oral corticosteroid such as prednisone in moderate to high dose is the mainstay of medical therapy and is given to slow down the rate of disease progression. Hydroxychloroquine may reduce the photosensitive rash. Note that adverse cutaneous reactions to hydroxychloroquine are reported to affect more than 30% of patients with dermatomyositis, compared to a lower risk of. Hydroxychloroquine is cheap, relatively safe, and controls the heart and muscle inflammation associated with dermatomyositis. Hydroxychloroquine controls heart and muscle inflammation This past weekend, I ran out of hydroxychloroquine, an antimalarial drug used to treat autoimmune diseases.